中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/03 | 3,800 | 3,807 | 3,765 | 3,783 | -7 | -0.2% | 1,566,200 |
| 2022/03/02 | 3,866 | 3,872 | 3,782 | 3,790 | -47 | -1.2% | 1,830,700 |
| 2022/03/01 | 3,806 | 3,894 | 3,806 | 3,837 | +37 | +1% | 2,196,900 |
| 2022/02/28 | 3,852 | 3,858 | 3,780 | 3,800 | -53 | -1.4% | 2,226,200 |
| 2022/02/25 | 3,885 | 3,913 | 3,844 | 3,853 | +2 | +0.1% | 2,135,700 |
| 2022/02/24 | 3,860 | 3,929 | 3,841 | 3,851 | -24 | -0.6% | 2,458,100 |
| 2022/02/22 | 3,875 | 3,982 | 3,830 | 3,875 | -34 | -0.9% | 2,046,100 |
| 2022/02/21 | 3,849 | 3,943 | 3,827 | 3,909 | +1 | ±0% | 1,392,200 |
| 2022/02/18 | 3,826 | 3,920 | 3,825 | 3,908 | +40 | +1% | 1,673,200 |
| 2022/02/17 | 3,980 | 3,992 | 3,866 | 3,868 | -147 | -3.7% | 1,843,600 |
| 2022/02/16 | 4,006 | 4,040 | 3,988 | 4,015 | +54 | +1.4% | 1,944,000 |
| 2022/02/15 | 3,946 | 3,983 | 3,933 | 3,961 | +6 | +0.2% | 1,728,200 |
| 2022/02/14 | 3,980 | 4,014 | 3,931 | 3,955 | -116 | -2.8% | 2,058,200 |
| 2022/02/10 | 4,116 | 4,183 | 4,053 | 4,071 | -29 | -0.7% | 2,673,200 |
| 2022/02/09 | 4,092 | 4,123 | 4,073 | 4,100 | -6 | -0.1% | 2,741,500 |
| 2022/02/08 | 4,042 | 4,120 | 4,032 | 4,106 | +47 | +1.2% | 2,387,100 |
| 2022/02/07 | 3,977 | 4,068 | 3,957 | 4,059 | +79 | +2% | 2,491,100 |
| 2022/02/04 | 3,830 | 4,019 | 3,808 | 3,980 | +177 | +4.7% | 4,367,900 |
| 2022/02/03 | 3,815 | 3,845 | 3,777 | 3,803 | -17 | -0.4% | 1,721,300 |
| 2022/02/02 | 3,788 | 3,845 | 3,769 | 3,820 | +102 | +2.7% | 2,104,200 |
| 2022/02/01 | 3,706 | 3,747 | 3,677 | 3,718 | +7 | +0.2% | 1,840,500 |
| 2022/01/31 | 3,746 | 3,746 | 3,668 | 3,711 | -38 | -1% | 2,190,100 |
| 2022/01/28 | 3,629 | 3,762 | 3,616 | 3,749 | +188 | +5.3% | 2,569,200 |
| 2022/01/27 | 3,693 | 3,693 | 3,545 | 3,561 | -136 | -3.7% | 2,488,900 |
| 2022/01/26 | 3,700 | 3,729 | 3,670 | 3,697 | -1 | ±0% | 1,881,300 |
| 2022/01/25 | 3,730 | 3,739 | 3,676 | 3,698 | +6 | +0.2% | 2,598,500 |
| 2022/01/24 | 3,658 | 3,719 | 3,652 | 3,692 | +12 | +0.3% | 1,501,800 |
| 2022/01/21 | 3,674 | 3,697 | 3,637 | 3,680 | -9 | -0.2% | 2,126,900 |
| 2022/01/20 | 3,636 | 3,711 | 3,623 | 3,689 | +53 | +1.5% | 1,756,900 |
| 2022/01/19 | 3,710 | 3,723 | 3,616 | 3,636 | -97 | -2.6% | 2,047,200 |
| 2022/01/18 | 3,748 | 3,748 | 3,694 | 3,733 | -4 | -0.1% | 1,364,000 |
| 2022/01/17 | 3,783 | 3,805 | 3,726 | 3,737 | -13 | -0.3% | 1,160,000 |
| 2022/01/14 | 3,694 | 3,750 | 3,686 | 3,750 | +19 | +0.5% | 2,737,200 |
| 2022/01/13 | 3,810 | 3,816 | 3,727 | 3,731 | -94 | -2.5% | 1,828,500 |
| 2022/01/12 | 3,778 | 3,868 | 3,761 | 3,825 | +56 | +1.5% | 2,253,600 |
| 2022/01/11 | 3,738 | 3,769 | 3,686 | 3,769 | +44 | +1.2% | 2,106,800 |
| 2022/01/07 | 3,741 | 3,766 | 3,672 | 3,725 | -9 | -0.2% | 2,622,100 |
| 2022/01/06 | 3,797 | 3,824 | 3,734 | 3,734 | -61 | -1.6% | 2,164,600 |
| 2022/01/05 | 3,834 | 3,842 | 3,786 | 3,795 | -33 | -0.9% | 2,069,700 |
| 2022/01/04 | 3,770 | 3,839 | 3,714 | 3,828 | +93 | +2.5% | 1,959,600 |
| 2021/12/30 | 3,765 | 3,789 | 3,735 | 3,735 | -37 | -1% | 1,555,700 |
| 2021/12/29 | 3,764 | 3,801 | 3,742 | 3,772 | -25 | -0.7% | 1,185,700 |
| 2021/12/28 | 3,737 | 3,808 | 3,736 | 3,797 | +50 | +1.3% | 1,583,200 |
| 2021/12/27 | 3,740 | 3,772 | 3,728 | 3,747 | -22 | -0.6% | 1,339,300 |
| 2021/12/24 | 3,750 | 3,775 | 3,738 | 3,769 | +19 | +0.5% | 1,094,400 |
| 2021/12/23 | 3,728 | 3,750 | 3,705 | 3,750 | +8 | +0.2% | 1,148,900 |
| 2021/12/22 | 3,703 | 3,748 | 3,702 | 3,742 | +42 | +1.1% | 1,759,400 |
| 2021/12/21 | 3,679 | 3,712 | 3,650 | 3,700 | +83 | +2.3% | 2,216,500 |
| 2021/12/20 | 3,612 | 3,676 | 3,591 | 3,617 | +5 | +0.1% | 2,576,500 |
| 2021/12/17 | 3,694 | 3,720 | 3,612 | 3,612 | -198 | -5.2% | 4,377,800 |
851～
900
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 627,700円 | +1.7% | +5.0% | 3.98% | 25.20倍 | 5.20倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 武 田 | 458,100円 | -1.1% | +75.3% | 4.37% | 31.73倍 | 1.04倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 第一三共 | 371,700円 | +6.0% | +4.0% | 2.10% | 22.93倍 | 4.24倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 大塚ＨＤ | 804,500円 | +2.2% | +28.0% | 1.74% | 12.88倍 | 1.56倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 168,400円 | +0.9% | +380.2% | 4.63% | 23.20倍 | 2.00倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
